| Functions of p38 MAP kinases in the central nervous system PR Asih, E Prikas, K Stefanoska, ARP Tan, HI Ahel, A Ittner Frontiers in molecular neuroscience 13, 570586, 2020 | 103 | 2020 |
| An N-terminal motif unique to primate tau enables differential protein–protein interactions K Stefanoska, A Volkerling, J Bertz, A Poljak, YD Ke, LM Ittner, A Ittner Journal of Biological Chemistry 293 (10), 3710-3719, 2018 | 61 | 2018 |
| Early‐onset axonal pathology in a novel P 301 S‐T au transgenic mouse model of frontotemporal lobar degeneration J van Eersel, CH Stevens, M Przybyla, A Gladbach, K Stefanoska, ... Neuropathology and applied neurobiology 41 (7), 906-925, 2015 | 58 | 2015 |
| Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation K Stefanoska, M Gajwani, ARP Tan, HI Ahel, PR Asih, A Volkerling, ... Science advances 8 (27), eabl8809, 2022 | 44 | 2022 |
| Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour K Stefanoska, J Bertz, AM Volkerling, J van der Hoven, LM Ittner, A Ittner Scientific reports 8 (1), 14296, 2018 | 33 | 2018 |
| Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ A Ittner, PR Asih, ARP Tan, E Prikas, J Bertz, K Stefanoska, Y Lin, ... Acta neuropathologica 140, 279-294, 2020 | 26 | 2020 |
| Tau target identification reveals NSF‐dependent effects on AMPA receptor trafficking and memory formation E Prikas, E Paric, PR Asih, K Stefanoska, H Stefen, T Fath, A Poljak, ... The EMBO Journal 41 (18), e10242, 2022 | 17 | 2022 |
| CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation YD Ke, G Chan, K Stefanoska, C Au, M Bi, J Müller, M Przybyla, A Feiten, ... Journal of Biological Chemistry 294 (38), 14149-14162, 2019 | 16 | 2019 |
| Interaction between the guanylate kinase domain of PSD-95 and the proline-rich region and microtubule binding repeats 2 and 3 of tau E Prikas, H Ahel, K Stefanoska, PR Asih, A Volkerling, LM Ittner, A Ittner Biochemistry and Cell Biology 99 (5), 606-616, 2021 | 8 | 2021 |
| Early-onset axonal pathology in a novel P301S-tau transgenic mouse model of frontotemporal dementia J van Ersel, CH Stevens, M Przybyla, A Gladbach, K Stefanoska, C Chan, ... Neuropathology Appl Neurobiol., 2015 | 5 | 2015 |
| Alzheimer’s disease and Frontotemporal lobar degeneration: mouse models LM Ittner, WS Lee, K Stefanoska, PR Asih, YD Ke Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and …, 2018 | 2 | 2018 |
| Remote memory engrams are controlled by encoding-specific tau phosphorylation K Stefanoska, E Prikas, Y Lin, R Kosonen, A Ittner bioRxiv, 2023.12. 01.569663, 2023 | 1 | 2023 |
| High level forebrain expression of active tau kinase p38γ exacerbates cognitive dysfunction in aged APP-transgenic Alzheimer’s mice PR Asih, K Stefanoska, E Prikas, A Ittner Neuroscience 484, 53-65, 2022 | 1 | 2022 |
| Investigating protein kinases, protein interactions and mechanisms of multi-site phosphorylation of the microtubule-associated protein tau K Stefanoska Macquarie University, 2023 | | 2023 |
| Reduction of advanced tau‐mediated memory deficits by the MAP kinase p38γ PR Asih, K Stefanoska, A Ittner Alzheimer's & Dementia 17, e054596, 2021 | | 2021 |
| Characterisation of a novel P301S mutant tau transgenic mouse model JV Eersel, CH Stevens, M Przybyla, A Gladbach, K Stefanoska, ... JOURNAL OF NEUROCHEMISTRY 134, 330-330, 2015 | | 2015 |
| Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration L Ittner, J Kril, G Sutherland, D Abramowski, CKX Chan, A Gladbach, ... Wiley-Blackwell Publishing, 2015 | | 2015 |
